Hope for this and many other diseases is fueled by a United Kingdom researcher who is trying to develop delivery systems that bypass these faulty cell membrane proteins to properly orchestrate the ...
Biotechnology company Nuclera, which enables access to high quality proteins, has launched its nanodisc panel to support screening and scale-up of G-protein coupled receptors (GPCRs). “Since releasing ...
Zeiss has unveiled the new Zeiss Crossbeam 750 focused ion beam-scanning electron microscope (FIB-SEM), optimised for demanding sample preparation. It can provide a live, high-resolution “see while ...
Lundbeck will be presenting its research at the 2026 Alzheimer’s and Parkinson’s Disease conference Lundbeck has shared that new data from a Phase 1b proof-of-mechanism trial of Lu AF28996, a novel ...
Recombinant technology specialist Sino Biological has launched the XPressMAX Cell-Free Protein Synthesis Kit (Cat#: CFKIT02). The solution is designed to supercharge AI-driven high-throughput ...
Imaging CRO Qureight will use its end-to-end imaging technology and services in a clinical trial analysing diffuse cutaneous Systemic Sclerosis (dcSSc). SSc is a complex disease characterised by ...
Servier, an independent international pharmaceutical company governed by a foundation, and n-Lorem Foundation, a non-profit organisation established to provide experimental medicines to patients with ...
A recent study published in Neurology has developed an AI tool to improve diagnostics accuracy in Alzheimer’s disease and related dementias. The results showed that AIDD identified the two diseases ...
As the oncology drug pipeline faces unprecedented target saturation, industrial R&D teams are actively seeking sophisticated molecular architectures that offer superior selectivity, accelerated ...
AndzonBio2 has signed agreements with the Alborada Drug Discovery Institute (ADDI) at the University of Cambridge and Cambridge Enterprise to advance a new class of therapeutics targeting ...
CCRM and CDMO subsidiary OmniaBio have partnered with Avectas to evaluate its automated, integrated, and scalable cell therapy manufacturing platform. The evaluation will explore how Avectas’ platform ...
Waters Corporation has launched a the Xevo MRT P10 mass spectrometer, a high-resolution Quadrupole Time-of-Flight (QToF) system for high-throughput multiomics, bioanalysis and biopharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results